420 with CNW – Study Finds Vaping Related Lung Injuries Were Few in States with Legal Marijuana

From August to November 2019, the nation was rocked with a crisis. Over 2,200 individuals were affected by e-cigarette or vaping, product use associated lung injury (EVALI), with over 47 individuals dying in 25 states. And with the growing popularity of vaping as a safe alternative to smoking, the crisis left the cannabis industry in quite a precarious position.

“The popularity of vaping is a central pillar of our forecasts of the future growth of cannabis sales, so it’s crucial for cannabis industry professionals to understand the impact the vaping crisis will have on the market and how best to adjust business strategies in its wake,” stated A Review Market Research and BDS Analytics.

While the crisis provided the anti-marijuana movement with ammunition against the nascent industry, marijuana reform advocates claimed that most of the cases were in states where marijuana was illegal. And according to a study published in an American Medical Association Journal, it seems they may have been right.

After analyzing the Centers for Disease Control and Prevention Data (CDC) on EVALI cases, researchers found that people in states where recreational marijuana is legal were significantly less likely to experience vaping related injuries than those in states where recreational marijuana is illegal.

The crisis was traced back to contaminated vaping cartridges, and people were more likely to find such defective vapes on the black market, compared to retail stores that sell tested and approved products. Published by the JAMA Network Open, the research letter shows that states with recreational marijuana shops had 1.7 EVALI cases per 1 million people while states without had 8.1 cases per I million people.

“The data suggests that EVALI cases were concentrated in states where consumers do not have legal access to recreational marijuana dispensaries. This association was not driven by state-level differences in e-cigarette use, and EVALI case rates were not associated with state-level prevalence of e-cigarette use. One possible inference is that the presence of legal markets for marijuana has helped mitigate or may be protective against EVALI.”

The researchers surmised that it is “possible that people in recreational states tend to purchase marijuana products at legal dispensaries, which may be less likely to sell the contaminated products that are thought to cause EVALI.”

This proves the theory that many industry stakeholders and observers have put forth: legalization is a great way to set quality control standards and ultimately, safeguard public health.

“It appears states that have legal access to marijuana have lower rates of EVALI cases which is consistent with the hypothesis that people have demand for marijuana products, and in states where they don’t have access to them in this regulatory fashion, they end up purchasing them elsewhere,” says study co-author Alex Hollingsworth.

These research findings are likely to vindicate cannabis industry players like The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) who have always believed that consumers have a chance to consume high-quality products when cannabis is legalized and regulated.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire AltMed Capital Corp.

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accelerate its advancements within the psychedelic medicine arena. On Thursday, Champignon Brands announced its plans to acquire a leading Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer (the “Transaction”) and has entered into a definitive agreement (the “Agreement”) to acquire 100% of AltMed Capital Corp. (“AltMed”). “Founded and operated by Dr. McIntyre, the CRTCE has the human capital and unmatched R&D capabilities, with respect to rapid onset treatments such as ketamine, to revolutionize the treatment of depression, PTSD and substance use disorders,” Gareth Birdsall, CEO of Champignon, said in the news release. “Champignon and AltMed will leverage Dr. McIntyre’s expertise, alongside the CRTCE’s existing SOPs, data-driven research sets and practitioner education modules, to roll out five unique ketamine clinics across Florida, California and the U.S. Eastern Seaboard. Our additional ketamine clinics are projected to be fully operational by Q4 2020. Furthermore, having previously completed funding rounds, our acquisition of AltMed will further bolster our corporate treasury.”

To view the full press release, visit http://cnw.fm/cf2R9

About Champignon Brands Inc.

Champignon Brands Inc. is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting pre-clinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Marijuana Industry in Colorado Helping Restaurant Employees

Up to now, the restaurant and cannabis industries have had an interesting relationship. When states started legalizing marijuana and the industry really started picking up, restaurants started feeling the strain. As Kevin Burke, General Manager of Denver-based restaurant Morin says, restaurants were already struggling with what was effectively negative fifteen percent unemployment. The growing popularity of cannabis-infused meals strained the already scarce human resource.

“Qualified cooks could walk across the street and get a fifty cents per hour raise, and when cannabis called, they were getting a two, three dollar per hour raise,” he says. He acknowledges that the industry isn’t always employee-centered, saying that the situation helped the restaurant sector to identify some shortcomings and make conditions better for employees.

“It forced restaurants to change for the better in my opinion,” says Burke. And now, as the world faces one of the greatest threats in recent times, the cannabis industry is helping restaurant workers once again.

The Coronavirus first appeared in Wuhan, China late last year and quickly spread to every continent except Antarctica. The virus has infected over 1.4 million individuals worldwide and left at least 87,000 dead. Most governments have taken drastic measures to curb the spread of the virus, and these measures have been anything but kind to the economy.

People are advised to self-isolate and all but the most essential businesses have been shut down for the time being. And while cannabis, fortunately, made the cut, restaurants have had to shut down. In fact, most states with legal marijuana have registered increased marijuana sales, and they have taken additional steps to make sure the industry runs as safely as possible. These include allowing curbside pickups and home deliveries.

Restaurants, on the other hand, have been hit hard, and the employees have suffered most. That’s where the cannabis sector comes in. Toby Ripsom, co-founder of Veritas Cannabis saw a way he could help the restaurant industry, one of the sectors that have been especially affected, and he took it.

“When we sat down as a company to update our HR policies in light of sick days piling up, we wanted to take care of our employees through it but also became attuned of an upcoming struggle to maintain capacity,” he says. His partner, Mike, reached out to a local restaurateur, Max MacKissock, who said he was being forced to lay off more and more employees. “Mike brought that to the rest of the ownership, and we filled a void.”

Additionally, the state has thrown its weight behind the whole thing, making it a lot easier and faster to certify new cannabis employees than it was before. “The Colorado Marijuana Enforcement Division made gaining a badge an expedited, online process. It was previously an in-person application and a tougher hurdle, logistically speaking. The state has been wonderful through this hardship!”

Analysts believe such stories coming out of Colorado give cannabis industry players like Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) the impetus that they need to think of even more ways to help out during this difficult time of the COVID-19 pandemic.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – COVID-19 Crisis Triggers Changes in Marijuana Consumer Behavior

It’s safe to say the world has never experienced something quite like the Coronavirus pandemic. Three months after appearing in Wuhan, China, the virus has infected more than 1.4 million individuals worldwide and claimed at least 87,000 lives. Countries have had to radically overhaul systems that have been in place for decades to help contain the virus. And many experts say things may not go back to ‘normal’ once the pandemic dies down.

One interesting development with the announcement of lockdowns in various U.S. states was the increased demand for marijuana. Both recreational and medical marijuana dispensaries were seeing increased sales as people stocked up. Soon after, most of the states with legal marijuana programs declared marijuana as essential, thus allowing the industry to keep running during the pandemic.

Although marijuana businesses haven’t been granted access to disaster relief loans, most states have passed emergency measures to allow them to transact with their customers under safer and more hygienic conditions. This includes allowing curbside pickups and home deliveries.

According to Vice, people tend to smoke, drink or eat poorly during times of great stress. Dubbed ‘headlines distress disorder,’ it has led to a surge in the sale of alcoholic beverages during stressful times such as the one we’re currently facing. Headset reports that U.S. adult-use markets have shown an average daily sales increase of 10%.

“Historically, alcohol sales frequently rise during times of economic distress, regional disasters, etc. There is no reason to believe that cannabis sales would be any different and there will likely be a prolonged upswing for the foreseeable future,” says Sue Bachorski, formerly with Constellation Brands for 30 years and currently with the House of Saka.

Data released by Headset as of April 2 shows that the type of cannabis products consumers have been buying has changed. Edibles recorded a 28% increase in sales and cannabis-infused beverages, which previously accounted for only 1% of the market, saw a 14% increase. The Coronavirus attacks the respiratory system, so you would expect consumers to opt out of smoking or vaping cannabis.

“In these uncertain and challenging times, it’s an encouraging silver lining to see cannabis consumers increasingly seeking out infused beverages. There are likely several factors affecting the recent rise in sales, but an important takeaway is that infused beverages are typically designed for individual consumption and can be consumed discreetly,” says Vertosa CEO Ben Larson.

“They are also an approachable, familiar way to consume cannabis for less experienced users and those looking to avoid smoking during this time.”

Experts believe that the cannabis industry, including Round Meadow Holdings Corp. and Sugarmade Inc. (OTCQB: SGMD), is studying these changes in consumer preferences and they will certainly adjust their strategies accordingly.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Aims to Support Mental Health, Develop Improved Treatments Using Psilocybin Mushrooms

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human-optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, offers a timely line of organic, non-GMO and vegan-certified products. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://cnw.fm/1lTHD). A recent article discussing the company reads, “The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin are being explored for opioid addiction, Alzheimer’s disease, post-traumatic stress, post-treatment Lyme disease syndrome, anorexia nervosa and alcohol use related to depression. . . . The use of mushrooms in the health industry is growing in credibility in both scientific and financial sectors, and laws around the use of psilocybin mushrooms and their derivatives are changing. This progress is providing companies such as SHRM the opportunity to support mental health and develop new and improved treatments. The opportunities aren’t only medicinal, so while Champignon is preparing large-scale production for clinical settings, the company is also focused on retail opportunities in the health and wellness market.”

To view the full article, visit http://cnw.fm/u2x6R

About Champignon Brands Inc.

Champignon Brands is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol-use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, Champignon is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or standalone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Agrify Makes Antimicrobial Products Available to Public as Critically Needed Sanitization Weapons in Fight Against COVID-19

Agrify, a developer of premium indoor grow solutions for the cannabis industry, today announced that it is making its antimicrobial products, normally used to mitigate environmental threats to cannabis crops, available to the public as critically needed sanitization weapons in the fight against COVID-19. According to the update, Agrify typically sells its Bluezone(R) and Enozo products to cannabis cultivators as critical solutions for mitigating environmental threats such as powdery mildew, botrytis and mold in cannabis cultivations. But Agrify understands, like companies such as Dyson, Carhartt and GE, that any applicable resources need to go toward helping keep people safe and healthy during this time of global crisis. “Agrify takes our employees’ health and safety seriously,” Agrify CEO Raymond Nobu Chang said in the news release. “We had Enozo bottles and a Bluezone(R) unit running in our office from the moment we got word of the virus.”

To view the full article, visit http://cnw.fm/YA2qu

About Agrify

Agrify sets the standard in precision cultivation for the cannabis industry. The company applies science and technology to maximize the genetic potential of the plant, regardless of climate and geographic location. Its integrated hardware and software system is designed to optimize crop yields and quality at competitive operating costs. The result is a consistent product for cultivators and their customers, always. Agrify is headquartered in Burlington, Massachusetts. For more information, visit the company’s website at www.Agrify.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Sells Approximately 900 Pounds of Cannabis Products Amidst Coronavirus Outbreak and End of Dry Season

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. and California cannabis marketplaces, today announced the sale of approximately 900 pounds of cannabis product from its core cultivation facility, NUGS Farm. According to CannabisBenchmarks.com, the average price of cannabis flower in the U.S. market was $1,588 per pound as of April 3, with prices moving higher over recent weeks. “We believe there are two factors driving cannabis prices higher right now,” Cannabis Strategic Ventures CEO Simon Yu said in the news release. “First, people are reacting to the coronavirus epidemic, which is producing anxiety and an instinct to hoard necessary goods. For many people, that includes cannabis. This is particularly true for those with medical marijuana prescriptions. Second, we are moving toward the end of the dry season, so supply is tapering out of the market as outdoor producers wind down inventories ahead of the new planting season. We are clearly benefitting from both of these dynamics right now, which should continue to drive performance over coming months.”

To view the full press release, visit http://cnw.fm/DYc4T

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Arizona Marijuana Campaigners Petition Supreme Court to Authorize Electronic Signature Gathering

The Coronavirus pandemic has ground the world to a complete halt. All but the most essential businesses have been closed and people are instructed to stay indoors and practice social distancing. Not only has the pandemic put a ton of strain on healthcare systems around the world, but it has also made most economic, social and political activities virtually impossible.

Drug legalization campaigns have been especially hit. With most people under lockdown to prevent the spread of the virus, signature collecting has been put on hold. However, activists in Arizona have petitioned the Supreme Court to allow electronic signature gathering. The measure to legalize marijuana is backed by Smart and Safe Arizona, and the group filed a petition requesting that the Supreme Court direct the Secretary of State to let them collect signatures digitally.

Fortunately, the state already has the necessary infrastructure in place. Residents can use a system called E-QuaL to sign ballot petitions for individual candidates, and activists argue that it can be redirected into collecting signatures. They claim that limiting the E-QuaL system to office-seekers is unconstitutional. However, since state law says that it can only be used for that purpose, we will have to wait for the Court’s decision.

“Legal access to E-QuaL for these citizen initiatives is the right thing for public health and democracy. Following Governor Doug Ducey’s stay at home order issued Monday and current CDC recommendations, gathering hundreds of thousands of signatures on paper, at people’s homes or in public spaces is impossible to do safely and responsibly during this pandemic. E-QuaL is a very reasonable remedy,” said a statement from the groups’ attorneys.

Although the state requires 237,645 signatures for statutory proposals, Arizona’s marijuana campaign has already collected more than 320,000. However, they have yet to be verified, and activists would like to continue collecting signatures to make sure their measure qualifies for the ballot.

The legalization measure would allow individuals 21 and older to possess up to an ounce of marijuana at a time and cultivate up to six plants for personal use. Cannabis sales would be taxed at 26%, and the tax revenue would be allocated to community colleges, developing infrastructure, justice reinvestment and public services such as firefighters and police.

It also contains several restrictive justice provisions such as individuals with prior marijuana convictions to petition the courts to have their records expunged as well as establishing a social equity ownership program.

It would be interesting to hear what cannabis industry actors like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) think of the likelihood of the highest court in Arizona granting the request of the petitioners to collect electronic signatures in support of their cause.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Delaware Officials Authorize Medical Cannabis Deliveries Amid Coronavirus Crisis

Most states with legal cannabis programs have deemed marijuana essential as the world grapples with the Coronavirus pandemic. To reduce new infections and curb the spread of the virus, numerous governments all over the world have ordered lockdowns of varying degrees. Residents have been advised to stay indoors unless they absolutely have to, and all but the most essential businesses have been closed for the time being.

Fortunately for the millions of patients who rely on medical marijuana, marijuana was included in this category. With the exception of Massachusetts which has only allowed medical marijuana stores to remain open, all the other states have deemed both medical and recreational pot essential.

A large percentage of medical marijuana patients are senior citizens and immunocompromised individuals, and this puts them at greater risk. To keep both them and the staff safe, states have taken extra steps to help reduce their contact. In Delaware, officials have recently allowed medical marijuana home delivery under an emergency program to ensure patients receive their medicine while limiting their exposure.

One company, Columbia Care, has stores in Wilmington, Smyrna, and Rehoboth Beach, and it is expected to begin home deliveries as soon as this week. Although the program has been rolled out under Delaware’s state of emergency declaration, regulators have stated that they intend to allow deliveries to continue even after the virus runs its course.

“The Office of Medical Marijuana is not establishing this as a convenience option, but as a stop-gap system to allow homebound and the most vulnerable patients to obtain products safely,” says Paul Hyland, Director of the State Office of Medical Marijuana. He added that although there are still a number of steps to be completed and no firm date has been set for when deliveries will begin, ‘Columbia Care is looking to launch delivery this week.’

The emergency program could ultimately expand to other in-state dispensaries like First State Compassion and Fresh Delaware. “However at this time, they were not in a position to accommodate delivery in the time necessary to respond to the current situation,” says Hyland.

He adds that patients won’t be forced to take any extra steps to register for Columbia Care’s delivery service.

Leading cannabis advocacy group NORML has registered its approval of the emergency measure, stating that it is thrilled, and it has urged officials to implement the plan quickly. The group has also asked patients to only use the delivery option if they simply cannot do curbside pickups.

“Please be mindful that for many patients this will be their only option. If you can facilitate the online ordering with pick up option safely, please continue to do so and save this service for those who need it most.”

Analysts see this quick response by the regulators in Delaware to expedite the start of home deliveries as something that will be applauded by sector players like SinglePoint Inc. (OTCQB: SING) who are concerned that the ongoing COVID-19 control measures will make it harder for the most vulnerable patients across the affected countries to access medical cannabis.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Hemptown USA Offers Subscribers Opportunity to Pre-Order Leading Immunity-Boosting Product

Hemptown USA, a privately-owned grower of full-spectrum, feminized hemp using premium-seed genetics, recently lowered the price of its leading immunity-booster in response to the challenging times the world is facing, and the product rapidly sold out. Hemptown’s CBG IMMUNO CAPS are comprised of a proprietary blend of CBG (cannabigerol), CBD (cannabinoid), echinacea, elderberry, oregano and thyme. Now the company is offering Hemptown subscribers the opportunity to pre-order the product at the new price point of $59.99 before it becomes available to the general public. Products are anticipated to ship by Friday, April 10. Additionally, shoppers can boost their savings by bundling their purchase of IMMUNO CAPS with the company’s Harvest Blend CBD/CBG tincture for the low price of $99.99.

To pre-order Hemptown’s CBG IMMUNO CAPS, visit http://cnw.fm/5tY0b

About Hemptown USA

Hemptown USA is growing some of the finest cannabinoid-rich hemp plants in the world to meet the ever-increasing global demand for premium cannabinoid products. In total, the company cultivated more than 1,500 acres in three states – Oregon, Colorado and Kentucky. Expanded farmland spanning three states, together with extraction and processing capabilities, are the foundation for Hemptown USA’s vertically integrated model as the company pushes into the consumer packaged goods sectors with top-quality branded product lines. Due in large part to the recent acquisition of Kirkman Group, an FDA-licensed and cGMP (Current Good Manufacturing Practice) certified operating nutraceutical business based in Oregon, Hemptown USA is well-positioned to capitalize on a global market expected to exceed $22 billion by 2020. For more information, visit the company’s website at www.HemptownUSA.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.